Literature DB >> 18032656

Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes.

Eliseo A Eugenin1, Joan W Berman.   

Abstract

Human immunodeficiency virus (HIV) entry into the CNS is an early event after infection, resulting in neurological dysfunction in a significant number of individuals. As people with acquired immunodeficiency syndrome (AIDS) live longer, the prevalence of cognitive impairment is increasing, despite antiretroviral therapy. The mechanisms that mediate CNS dysfunction are still not completely understood, and include inflammation, viral presence, and/or replication. In this report, we characterize a novel role of gap junctions in transmitting and thereby amplifying toxic signals originating from HIV-infected astrocytes that trigger cell death in uninfected astrocytes. HIV-infected astrocytes were resistant to apoptosis; however, uninfected astrocytes forming gap junctions with infected astrocytes were apoptotic. Gap junction blockers abolished apoptosis in uninfected astrocytes, supporting the role of these channels in amplifying cell death. Our findings describe a novel mechanism of toxicity within the brain, triggered by low numbers of HIV-infected astrocytes and amplified by gap junctions, contributing to the pathogenesis of NeuroAIDS.

Entities:  

Mesh:

Year:  2007        PMID: 18032656      PMCID: PMC2117380          DOI: 10.1523/JNEUROSCI.4154-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals.

Authors:  S F An; M Groves; F Gray; F Scaravilli
Journal:  J Neuropathol Exp Neurol       Date:  1999-11       Impact factor: 3.685

2.  DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.

Authors:  T B Geijtenbeek; D S Kwon; R Torensma; S J van Vliet; G C van Duijnhoven; J Middel; I L Cornelissen; H S Nottet; V N KewalRamani; D R Littman; C G Figdor; Y van Kooyk
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

Review 3.  Brain-immune connection: immuno-regulatory properties of CNS-resident cells.

Authors:  B Becher; A Prat; J P Antel
Journal:  Glia       Date:  2000-02-15       Impact factor: 7.452

Review 4.  Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system.

Authors:  Avindra Nath; Ned Sacktor
Journal:  Curr Opin Neurol       Date:  2006-08       Impact factor: 5.710

Review 5.  Dementia and neurocognitive disorders due to HIV-1 infection.

Authors:  Beau M Ances; Ronald J Ellis
Journal:  Semin Neurol       Date:  2007-02       Impact factor: 3.420

6.  Herpes simplex virus-type 2 infectivity and agents that block gap junctional intercellular communication.

Authors:  Maureen T Knabb; Casey A Danielsen; Kerry McShane-Kay; Gustave K N Mbuy; Richard I Woodruff
Journal:  Virus Res       Date:  2006-12-08       Impact factor: 3.303

Review 7.  Connexin channel permeability to cytoplasmic molecules.

Authors:  Andrew L Harris
Journal:  Prog Biophys Mol Biol       Date:  2007-03-19       Impact factor: 3.667

8.  HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes.

Authors:  Eliseo A Eugenin; Jessie E King; Avindra Nath; Tina M Calderon; R Suzanne Zukin; Michael V L Bennett; Joan W Berman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

9.  Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE).

Authors:  Yuri Persidsky; David Heilman; James Haorah; Marina Zelivyanskaya; Raisa Persidsky; Gregory A Weber; Hiroaki Shimokawa; Kozo Kaibuchi; Tsuneya Ikezu
Journal:  Blood       Date:  2006-02-14       Impact factor: 22.113

Review 10.  Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.

Authors:  Clarisa M Buckner; Aimée J Luers; Tina M Calderon; Eliseo A Eugenin; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2006-04-13       Impact factor: 4.147

View more
  89 in total

1.  Rebound from Inhibition: Self-Correction against Neurodegeneration?

Authors:  Shobhana Sivaramakrishnan; William P Lynch
Journal:  J Clin Cell Immunol       Date:  2017-03-13

2.  PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation.

Authors:  Toni K Roberts; Eliseo A Eugenin; Susan Morgello; Janice E Clements; M Christine Zink; Joan W Berman
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

3.  Cytochrome C dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium-dependent mechanism.

Authors:  Eliseo A Eugenin; Joan W Berman
Journal:  J Neurochem       Date:  2013-10-20       Impact factor: 5.372

4.  Dynasore disrupts trafficking of herpes simplex virus proteins.

Authors:  Mascha B Mues; Natalia Cheshenko; Duncan W Wilson; Leslie Gunther-Cummins; Betsy C Herold
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

5.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

6.  Methamphetamine compromises gap junctional communication in astrocytes and neurons.

Authors:  Paul Castellano; Chisom Nwagbo; Luis R Martinez; Eliseo A Eugenin
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

Review 7.  Large animal models of neurological disorders for gene therapy.

Authors:  Christine Gagliardi; Bruce A Bunnell
Journal:  ILAR J       Date:  2009

Review 8.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

9.  Pannexin1 hemichannels are critical for HIV infection of human primary CD4+ T lymphocytes.

Authors:  J A Orellana; S Velasquez; D W Williams; J C Sáez; J W Berman; E A Eugenin
Journal:  J Leukoc Biol       Date:  2013-03-01       Impact factor: 4.962

Review 10.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.